http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-945672-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D04B35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 1960-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1964-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-945672-A
titleOfInvention Pyrazole sulphonamide compounds
abstract The invention comprises pyrazole sulphonamides of the formula: <FORM:0945672/C2/1> and alkali-metal salts thereof, wherein X is pyridyl, p-sulphamoylphenyl, p-carboxyphenyl, methyl or hydrogen, Y is methyl or carboxyl and Z is hydrogen or SO2NR1R2, wherein R1 and R2 are hydrogen or C1-5 alkyl or are joined to form a C1-10 alkylene group, X and Z being selected so that the pyrazole contains at least one sulphamoyl or substituted sulphamoyl group. Preferably X is pyridyl, p-sulphamoylphenyl or p-carboxyphenyl, Y is methyl or carboxyl and Z is hydrogen or sulphamoyl. The compounds are made by treating the corresponding 4-unsubstituted pyrazole with chlorosulphonic acid and reacting the resulting sulphonyl chloride with ammonia; or in the cases where X is p-sulphamoylphenyl, Z is hydrogen and Y is methyl or carboxyl, by reacting sulphamoylphenyl hydrazine with acetylacetone or ethyl acetopyruvate, respectively. Pyrazole compounds used as starting materials i.e. 1-(2-pyridyl)-3, 5-dimethylpyrazole and 1-(p-carboxyphenyl)-3 5-dimethylpyrazole are made by treating the appropriate substituted hydrazine with acetylacetone. Pharmaceutical preparations having diuretic activity comprise the above compounds of the invention and an inert pharmaceutical diluent. The preparations suitably take the form of tablets for oral administration or solutions, preferably in an isotonic aqueous medium, for injection.
priorityDate 1959-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410930699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408341817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20510982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID676764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425914843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422803044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17928041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546206

Total number of triples: 42.